4.7 Article

Structure-Function Correlation of Aminated Poly(α)glutamate as siRNA Nanocarriers

Journal

BIOMACROMOLECULES
Volume 17, Issue 9, Pages 2787-2800

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.biomac.6b00555

Keywords

-

Funding

  1. European Research Council under European Union/ERC [617445]
  2. European Research Council (ERC) [617445] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

It has been two decades since cationic polymers were introduced to the world of oligonucleotides delivery. However, the optimal physicochemical properties to make them a successful delivery vehicle are yet unknown. An ideal system became particularly interesting and necessary with the introduction of RNA interference as a promising therapeutic approach. Such nanocarrier should overcome challenges such as low plasma stability, poor cellular internalization and endosomal escape to induce gene silencing. To that end, we synthesized a library of biodegradable aminated poly(a)glutamate varied by amine moieties. In an attempt to elucidate the structure function relationship, our polyplexes were physicochemically characterized and their silencing activity and cytotoxicity were evaluated. We found several structures that demonstrated improved cellular internalization. These candidates silenced gene expression to less than 50% of their initial levels, while being safe to cells and mice. Based on our research, an improved and promising tailor-designed siRNA delivery platform can be developed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Nanoscience & Nanotechnology

Immune-mediated approaches against COVID-19

Helena F. Florindo, Ron Kleiner, Daniella Vaskovich-Koubi, Rita C. Acurcio, Barbara Carreira, Eilam Yeini, Galia Tiram, Yulia Liubomirski, Ronit Satchi-Fainaro

NATURE NANOTECHNOLOGY (2020)

Article Multidisciplinary Sciences

Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis

Lea Monteran, Nour Ershaid, Idan Sabah, Ibrahim Fahoum, Yael Zait, Ophir Shani, Noam Cohen, Anat Eldar-Boock, Ronit Satchi-Fainaro, Neta Erez

SCIENTIFIC REPORTS (2020)

Correction Biology

Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome (vol 16, 163, 2020)

Lee Shaashua, Anabel Eckerling, Boaz Israeli, Gali Yanovich, Ella Rosenne, Suzana Fichman-Horn, Ido Ben Zvi, Liat Sorski, Rita Haldar, Ronit Satchi-Fainaro, Tamar Geiger, Erica K. Sloan, Shamgar Ben-Eliyahu

BMC BIOLOGY (2020)

Review Pharmacology & Pharmacy

Preclinical models and technologies to advance nanovaccine development

Carina Peres, Ana Matos, Liane I. F. Moura, Rita C. Acurcio, Barbara Carreira, Sabina Pozzi, Daniella Vaskovich-Koubi, Ron Kleiner, Ronit Satchi-Fainaro, Helena F. Florindo

Summary: Targeted immunotherapies have revolutionized cancer treatment, but tumor heterogeneity and immunosuppression mechanisms have hindered the success of cancer vaccines. Nanotechnology offers promising solutions, but the selection of appropriate preclinical models is crucial.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Cell Biology

Proteogenomics of glioblastoma associates molecular patterns with survival

Gali Yanovich-Arad, Paula Ofek, Eilam Yeini, Mariya Mardamshina, Artem Danilevsky, Noam Shomron, Rachel Grossman, Ronit Satchi-Fainaro, Tamar Geiger

Summary: This study utilized high-resolution mass spectrometry proteomics and RNA sequencing to analyze 87 GBM patients, identifying specific immune, metabolic, and developmental processes associated with survival. The findings revealed a stronger association between proteomic profiles and survival, establishing proteomic heterogeneity in GBM as a key factor in understanding poor survival.

CELL REPORTS (2021)

Review Pharmacology & Pharmacy

Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?

Sabina Pozzi, Anna Scomparin, Sahar Israeli Dangoor, Daniel Rodriguez Ajamil, Paula Ofek, Lena Neufeld, Adva Krivitsky, Daniella Vaskovich-Koubi, Ron Kleiner, Pradip Dey, Shani Koshrovski-Michael, Noa Reisman, Ronit Satchi-Fainaro

Summary: Three-dimensional cancer models have been developed to study a wide range of biological applications, including cell signaling pathways, metastatic cascade steps, and personalized medicine, in vitro. By combining different cell types and external stimuli, these models can more accurately mimic the biology and pathophysiology of in vivo tumors.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Multidisciplinary Sciences

P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression

Eilam Yeini, Paula Ofek, Sabina Pozzi, Nitzan Albeck, Dikla Ben-Shushan, Galia Tiram, Sapir Golan, Ron Kleiner, Ron Sheinin, Sahar Israeli Dangoor, Shlomit Reich-Zeliger, Rachel Grossman, Zvi Ram, Henry Brem, Thomas M. Hyde, Prerna Magod, Dinorah Friedmann-Morvinski, Asaf Madi, Ronit Satchi-Fainaro

Summary: The study revealed the crucial role of P-selectin in promoting GB proliferation and invasion, showing that inhibiting P-selectin could reduce tumor growth and increase survival in mouse models. The findings shed light on the function of tumor-associated microglia/macrophages and the mechanisms by which GB cells suppress the immune system and invade the brain, paving the way to exploit P-selectin as a target for GB therapy.

NATURE COMMUNICATIONS (2021)

Article Pharmacology & Pharmacy

Sulfonated Amphiphilic Poly(α)glutamate Amine-A Potential siRNA Nanocarrier for the Treatment of Both Chemo-Sensitive and Chemo-Resistant Glioblastoma Tumors

Adva Krivitsky, Sabina Pozzi, Eilam Yeini, Sahar Israeli Dangoor, Tal Zur, Sapir Golan, Vadim Krivitsky, Nitzan Albeck, Evgeny Pisarevsky, Paula Ofek, Asaf Madi, Ronit Satchi-Fainaro

Summary: The use of a sulfonated amphiphilic poly(alpha)glutamate nanocarrier decorated with sulfonate groups shows potential for targeted siRNA delivery to GB brain tumors, leading to specific gene silencing and reduced cell viability in both chemo-sensitive and chemo-resistant GB cells. This approach may strengthen therapeutic applications of siRNA for chemo-resistant GB tumors and serve as a combination therapy for chemo-sensitive GB tumors.

PHARMACEUTICS (2021)

Review Pharmacology & Pharmacy

Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape

Luigi Battaglia, Anna Scomparin, Chiara Dianzani, Paola Milla, Elisabetta Muntoni, Silvia Arpicco, Roberta Cavalli

Summary: Cutaneous melanoma is an aggressive solid tumor with low survival rates, and current clinical treatments include various methods such as surgery, chemotherapy, immunotherapy, and targeted therapy. Nanotechnology-based delivery systems play a crucial role in improving therapeutic efficacy, especially in combination therapy. Italian researchers are focusing on developing nanoformulations for malignant melanoma therapy and there are numerous nanomedicines undergoing clinical trials in the country.

PHARMACEUTICS (2021)

Article Biochemistry & Molecular Biology

Lipid-Coated Nanocrystals as a Tool for Improving the Antioxidant Activity of Resveratrol

Monica Argenziano, Irfan Aamer Ansari, Elisabetta Muntoni, Rita Spagnolo, Anna Scomparin, Roberta Cavalli

Summary: This study aims to improve the antioxidant activity and bioavailability of trans-resveratrol by developing lipid-coated nanocrystals. The nanocrystals obtained through a milling method showed faster dissolution rate compared to the coarse powder and did not impair the antioxidant properties of trans-resveratrol. Oral administration of the lipid-coated nanocrystals to rats resulted in increased bioavailability of trans-resveratrol.

ANTIOXIDANTS (2022)

Article Medicine, Research & Experimental

MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression

Sabina Pozzi, Anna Scomparin, Dikla Ben-Shushan, Eilam Yeini, Paula Ofek, Alessio D. Nahmad, Shelly Soffer, Ariel Ionescu, Antonella Ruggiero, Adi Barzel, Henry Brem, Thomas M. Hyde, Iris Barshack, Sanju Sinha, Eytan Ruppin, Tomer Weiss, Asaf Madi, Eran Perlson, Inna Slutsky, Helena F. Florindo, Ronit Satchi-Fainaro

Summary: Resistance to chemo- and immunotherapies often develops in melanoma brain metastasis (MBM), with the brain microenvironment (BME) playing a role in promoting MBM progression. We found that monocyte chemoattractant protein-1 (MCP-1) and its receptors, CCR2 and CCR4, were overexpressed in MBM compared to primary lesions. We demonstrated that melanoma cells alter astrocyte secretome and induce MCP-1 expression and secretion, enhancing tumorigenic properties of melanoma cells. Pharmacological blockade of MCP-1 or molecular knockout of CCR2/CCR4 increased infiltration of cytotoxic CD8(+) T cells and attenuated the immunosuppressive phenotype of the BME, leading to decreased MBM growth and prolonged survival in mice.

JCI INSIGHT (2022)

Review Pharmacology & Pharmacy

Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation

Chiara Puricelli, Casimiro Luca Gigliotti, Ian Stoppa, Sara Sacchetti, Deepika Pantham, Anna Scomparin, Roberta Rolla, Stefania Pizzimenti, Umberto Dianzani, Elena Boggio, Salvatore Sutti

Summary: Chronic inflammation plays a role in the development of various diseases, but conventional anti-inflammatory drugs are not very effective and have adverse effects. Encapsulating bioactive molecules in nanoparticles (NPs) may enhance their pharmacological properties. Poly lactic-co-glycolic acid (PLGA) NPs are widely used due to their compatibility, degradability, and ability to control erosion time, hydrophilicity, and mechanical properties. This review focuses on the use of PLGA NPs in preclinical in vivo models of diseases characterized by chronic inflammation or imbalanced inflammatory responses.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Nanosponges as protein delivery systems: Insulin, a case study

Silvia Lucia Appleton, Maria Tannous, Monica Argenziano, Elisabetta Muntoni, Arianna Carolina Rosa, Davide Rossi, Fabrizio Caldera, Anna Scomparin, Francesco Trotta, Roberta Cavalli

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Article Biology

Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome

Lee Shaashua, Anabel Eckerling, Boaz Israeli, Gali Yanovich, Ella Rosenne, Suzana Fichman-Horn, Ido Ben Zvi, Liat Sorski, Rita Haldar, Ronit Satchi-Fainaro, Tamar Geiger, Erica K. Sloan, Shamgar Ben-Eliyahu

BMC BIOLOGY (2020)

Article Pharmacology & Pharmacy

Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in Melanoma

Evgeni Pisarevsky, Rachel Blau, Yana Epshtein, Dikla Ben-Shushan, Anat Eldar-Boock, Galia Tiram, Shani Koshrovski-Michael, Anna Scomparin, Sabina Pozzi, Adva Krivitsky, Gal Shenbach-Koltin, Eilam Yeini, Lidar Fridrich, Richard White, Ronit Satchi-Fainaro

ADVANCED THERAPEUTICS (2020)

No Data Available